Highbridge Capital Management, LLC 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | OnKure Therapeutics, Inc. OKUR | Highbridge Capital Management, LLC | 542,361 4.200% | -121,246 (-18.27%) | Filing |
| 2025-08-14 4:09 pm Purchase | 2025-06-30 | 13G | OnKure Therapeutics, Inc. OKUR | Highbridge Capital Management, LLC | 663,607 5.200% | 263,864 (+66.01%) | Filing |
| 2025-02-07 4:15 pm Purchase | 2024-12-31 | 13G | OnKure Therapeutics, Inc. OKUR | Highbridge Capital Management, LLC | 399,743 3.200% | 399,743 (New Position) | Filing |